United States

Kyorin Holdings Inc (4569.T)

4569.T on Tokyo Stock Exchange

18 Aug 2017
Change (% chg)

¥-42 (-1.80%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Kyorin Holdings to integrate production function
Thursday, 11 May 2017 04:02am EDT 

May 11 (Reuters) - Kyorin Holdings Inc <4569.T>:* Says it plans to set up new production subsidiary to take over business from Noshiro plant of unit Kyorin Pharmaceutical Company, Limited and manufacture division of KYORIN Rimedio Co.,Ltd..* Says it aims to complete integration as of April 2018.* Says other details remain to be decided later.  Full Article

Kyorin holdings likely will see 10 percent rise in group operating profit for year ending in March 2018 - Nikkei
Monday, 17 Apr 2017 01:18pm EDT 

April 17 (Reuters) - Nikkei:Kyorin Holdings likely will see a 10 percent rise in group operating profit for the year ending in March 2018 - Nikkei.Kyorin Holdings Inc's sales are seen slipping 3 percent to 112 billion yen for the year ending in March 2018 - Nikkei.  Full Article

KYORIN Holdings unit gets license from Merck for drug KRP-114V
Tuesday, 11 Apr 2017 01:45am EDT 

KYORIN Holdings Inc <4569.T> :Says its pharma unit receives license from US firm Merck & Co Inc for drug KRP-114V, a treatment for overactive bladder, owning exclusive rights to develop and commercialize in Asian area.  Full Article

R&I affirms KYORIN Holdings Inc's rating at "A-" and announces stable outlook -R&I
Thursday, 9 Feb 2017 01:39am EST 

KYORIN Holdings Inc <4569.T> : Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A-" -R&I .Rating outlook stable -R&I.  Full Article

Kyorin Holdings unit forms sales business alliance with Air Liquide Japan, Ltd.
Tuesday, 10 Jan 2017 09:32pm EST 

Kyorin Holdings Inc <4569.T>: Says its unit formed sales business alliance with Air Liquide Japan, Ltd. .Says two entities will cooperate on the marketing of hand hygiene products in Japan.  Full Article

KYORIN Holdings to transfer unit to Taisho Pharmaceutical
Monday, 26 Dec 2016 01:23am EST 

KYORIN Holdings Inc <4569.T>: Says it to transfer its Japan-based unit Dr.Program to Taisho Pharmaceutical Co., Ltd that is a unit of Taisho Pharmaceutical Holdings Co Ltd <4581.T> . Transaction price is not disclosed .Says the transaction planned effective on April 1, 2017.  Full Article

KYORIN Holdings unit grants MSD K.K. manufacturing and marketing rights for medicine of allergic diseases
Wednesday, 28 Sep 2016 12:23am EDT 

KYORIN Holdings Inc <4569.T>:Says MSD K.K. received a manufacturing and marketing approval for DESALEX® Tablets 5mg for the treatment of allergic diseases from the co's unit KYORIN Pharmaceutical Co., Ltd..  Full Article

Kaken Pharmaceutical to co-promote allergic medicine with Kyorin Holdings unit
Monday, 11 Jul 2016 02:00am EDT 

Kaken Pharmaceutical Co Ltd <4521.T>:Says the company entered into basic agreement with Kyorin Holdings Inc <4569.T>'s unit on co-promotion of an allergic medicine, whose exclusive sales right is owned by the Kyorin Holdings's unit.  Full Article

KYORIN Holdings unit to sign exclusive distribution agreement
Wednesday, 25 May 2016 02:30am EDT 

KYORIN Holdings Inc <4569.T>:Says company MSD to grant subsidiary KYORIN Pharmaceutical an exclusive distribution license for an allergic disease treatment drug in Japan changed from joint marketing.  Full Article

Kyorin and Kissei sign agreement for co-development and co-marketing of KRP-114V
Wednesday, 30 Mar 2016 02:00am EDT 

Kyorin Holdings Inc:KYORIN Pharmaceutical Co., Ltd., a wholly-owned subsidiary of KYORIN Holdings, Inc. and Kissei Pharmaceutical Co., Ltd. jointly announced a co-development and co-marketing agreement for an overactive bladder medication of KRP-114V (INN: Vibegron) which is being developed by Kyorin in Japan.  Full Article

BRIEF- Kyorin Holdings unit Kyorin Pharmaceutical to buy jTAS

* Says its unit Kyorin Pharmaceutical Co Ltd will acquire 100 percent stake in jTAS Inc